SUSMED,Inc. (TYO:4263)
Japan
· Delayed Price · Currency is JPY 1,028.00
+7.00 (0.69%)
At close: Mar 6, 2026
SUSMED,Inc. Income Statement
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 |
| Revenue | 480 | 462 | 342 | 530 | 316 | 115 | Upgrade
|
| Revenue Growth (YoY) | 220.00% | 35.09% | -35.47% | 67.72% | 174.78% | 238.24% | Upgrade
|
| Cost of Revenue | 16 | 12 | 12 | 8 | 11 | 9 | Upgrade
|
| Gross Profit | 464 | 450 | 330 | 522 | 305 | 106 | Upgrade
|
| Selling, General & Admin | 492 | 477 | 452 | 394 | 309 | 190 | Upgrade
|
| Research & Development | 250 | 273 | 243 | 176 | 226 | 249 | Upgrade
|
| Operating Expenses | 742 | 750 | 695 | 570 | 535 | 439 | Upgrade
|
| Operating Income | -278 | -300 | -365 | -48 | -230 | -333 | Upgrade
|
| Other Non Operating Income (Expenses) | 10 | 5 | 8 | 4 | 12 | 60 | Upgrade
|
| EBT Excluding Unusual Items | -268 | -295 | -357 | -44 | -218 | -273 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | -4 | Upgrade
|
| Asset Writedown | -2 | -4 | -2 | -5 | -15 | - | Upgrade
|
| Other Unusual Items | 15 | 2 | 3 | - | - | - | Upgrade
|
| Pretax Income | -255 | -297 | -356 | -49 | -233 | -277 | Upgrade
|
| Income Tax Expense | 2 | 1 | 1 | 1 | - | - | Upgrade
|
| Net Income | -257 | -298 | -357 | -50 | -233 | -277 | Upgrade
|
| Net Income to Common | -257 | -298 | -357 | -50 | -233 | -277 | Upgrade
|
| Shares Outstanding (Basic) | 17 | 17 | 17 | 16 | 15 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | 17 | 17 | 17 | 16 | 15 | 13 | Upgrade
|
| Shares Change (YoY) | 0.41% | 0.60% | 1.77% | 11.71% | 14.76% | 11.19% | Upgrade
|
| EPS (Basic) | -15.28 | -17.75 | -21.39 | -3.05 | -15.87 | -21.65 | Upgrade
|
| EPS (Diluted) | -15.28 | -17.75 | -21.39 | -3.05 | -15.87 | -21.65 | Upgrade
|
| Free Cash Flow | -436 | -436 | -233 | 94 | -177 | - | Upgrade
|
| Free Cash Flow Per Share | -25.92 | -25.96 | -13.96 | 5.73 | -12.05 | - | Upgrade
|
| Gross Margin | 96.67% | 97.40% | 96.49% | 98.49% | 96.52% | 92.17% | Upgrade
|
| Operating Margin | -57.92% | -64.94% | -106.73% | -9.06% | -72.78% | -289.56% | Upgrade
|
| Profit Margin | -53.54% | -64.50% | -104.39% | -9.43% | -73.73% | -240.87% | Upgrade
|
| Free Cash Flow Margin | -90.83% | -94.37% | -68.13% | 17.74% | -56.01% | - | Upgrade
|
| EBITDA | -272 | -293 | -360 | -43 | -228 | - | Upgrade
|
| EBITDA Margin | -56.67% | -63.42% | -105.26% | -8.11% | -72.15% | - | Upgrade
|
| D&A For EBITDA | 6 | 7 | 5 | 5 | 2 | - | Upgrade
|
| EBIT | -278 | -300 | -365 | -48 | -230 | -333 | Upgrade
|
| EBIT Margin | -57.92% | -64.94% | -106.73% | -9.06% | -72.78% | -289.56% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.